Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance

Antonios Chatzigeorgioua, Tom Seijkens, Barbara Zarzycka, David Engel, Marjorie Poggi, Susan van den Berg, Sjoerd van den Berg, Oliver Soehnlein, Holger Winkels, Linda Beckers, Dirk Lievens, Ann Driessen, Pascal Kusters, Erik Biessen, Ruben Garcia-Martin, Anne Klotzsche-von Ameln, Marion Gijbels, Randolph Noelle, Louis Boon, Tilman HackengKlaus Schulte, Aimin Xu, Gert Vriend, Sander Nabuurs, Kyoung-Jin Chung, Ko Willems van Dijk, Patrick C. N. Rensen, Norbert Gerdes, Menno de Winther, Norman L. Block, Andrew V. Schally, Christian Weber, Stefan R. Bornstein, Gerry Nicolaes, Triantafyllos Chavakis, Esther Lutgens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2686-2691
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number7
DOIs
Publication statusPublished - 18 Feb 2014

Keywords

  • metabolism
  • type 2 diabetes
  • immunity

Cite this